
|Articles|August 10, 2010
EGA Talks Biosimilars
The European Generic Medicines Association's Director for Scientific Affairs, Suzette Cox, talks to us about the environment for biosimilars.
Advertisement
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Eli Lilly Releases Open Letter Warning of Potential Safety Risks for Compounded Tirzepatide Plus Vitamin B12
2
What is Shadow AI and How is it Impacting Pharma Companies?
3
Novo Nordisk Responds to FDA’s Warning Letter Regarding 2025 PADE Inspection
4
Agentic AI and the Future of Commercial Excellence in Life Sciences
5




